2-(cyclopropylamino)acetonitrile | 30858-68-5

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-(cyclopropylamino)acetonitrile
• CAS: 30858-68-5
• 化学式: C₅H₈N₂
• mdl: MFCD09814630
• 分子量: 96.1319
• InChiKey: FSDQBPDUZVGCQQ-UHFFFAOYSA-N

物化性质

• 沸点：
  224.7±13.0 °C(Predicted)
• 密度：
  1.01±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  7
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  35.8
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(cyclopropylamino)acetonitrile 在 N-羟基-7-氮杂苯并三氮唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 、 三氟乙酸 作用下， 以 二氯甲烷 为溶剂， 生成 (2S)-2-amino-N-(cyanomethyl)-N-cyclopropyl-3,3-dimethylbutanamide
  参考文献：
  名称：

  Seco-prolinenitrile inhibitors of dipeptidyl peptidase IV define minimal pharmacophore requirements at P1

  摘要：

  A series of seco-prolinenitrile-containing dipeptides were synthesized and assayed as inhibitors of the N-terminal sequence-specific serine protease dipeptidyl peptidase IV, a promising new target for treatment of type 2 diabetes. The inhibitors described herein assess the minimum structural requirements at P1 for this enzyme, resulting in the identification of inhibitors with low nM potency. (C) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.11.098
• 作为产物：
  描述：

  环丙胺 、 溴乙腈 在 N,N-二异丙基乙胺 作用下， 以 甲苯 为溶剂， 以0.99 g的产率得到2-(cyclopropylamino)acetonitrile
  参考文献：
  名称：

  含氰烷基的新型七氟异丙基N-苯基吡唑芳酰胺：设计、合成、杀虫活性、对接研究和理论计算

  摘要：

   [显示省略]

  DOI：

  10.1016/j.bioorg.2023.107024

文献信息

• Dynamics in Catalytic Asymmetric Diastereoconvergent (3 + 2) Cycloadditions with Isomerizable Nitrones and α-Keto Ester Enolates
  作者：Tetsuya Ezawa、Yoshihiro Sohtome、Daisuke Hashizume、Masaya Adachi、Mai Akakabe、Hiroyuki Koshino、Mikiko Sodeoka

  DOI：10.1021/jacs.1c02833

  日期：2021.6.23

  Reaction design in asymmetric catalysis has traditionally been predicated on a structurally robust scaffold in both substrates and catalysts, to reduce the number of possible diastereomeric transition states. Herein, we present the stereochemical dynamics in the Ni(II)-catalyzed diastereoconvergent (3 + 2) cycloadditions of isomerizable nitrile-conjugated nitrones with α-keto ester enolates. Even in

  传统上，不对称催化中的反应设计基于底物和催化剂中结构坚固的支架，以减少可能的非对映异构过渡态的数量。在此，我们展示了 Ni(II) 催化的非对映会聚 (3 + 2) 环加成反应中的可异构化腈共轭硝酮与 α-酮酯烯醇化物的立体化学动力学。即使在存在多个平衡物种的情况下，催化协议也显示出广泛的底物范围，以访问一系列带有相邻立体中心的含 CN 构建块，具有高对映选择性和非对映选择性。我们的计算研究表明，在去质子化过程中形成 ( Z )-Ni-烯醇化物的过程中控制了对映选择性，而独特的合成 添加主要由硝酮和配体之间的弱非共价键相互作用控制。
• Indole nitriles
  申请人：Roche Palo Alto LLC

  公开号：US06759428B2

  公开（公告）日：2004-07-06

  Compounds of the formula (I) wherein m, n, R1, R2, R3, R4, R5 and R6 are as described herein, together with methods for making the compounds and using the compounds for treatment of diseases or conditions mediated by Cathepsin K.

  公式(I)的化合物： 其中m、n、R1、R2、R3、R4、R5和R6如本文所述，以及制造这些化合物的方法以及使用这些化合物治疗由组织蛋白酶K介导的疾病或病症的方法。
• [EN] ISOQUINOLINE POTASSIUM CHANNEL INHIBITORS<br/>[FR] INHIBITEURS DE CANAL POTASSIQUE D'ISOQUINOLINE
  申请人：MERCK & CO INC

  公开号：WO2005030729A1

  公开（公告）日：2005-04-07

  The present invention relates to compounds of structural formula I: I useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.

  这项发明涉及结构式I的化合物：I，用作钾通道抑制剂，用于治疗心律失常等。
• Heteroaryl nitriles
  申请人：——

  公开号：US20030212097A1

  公开（公告）日：2003-11-13

  The present invention relates to compound of formula (I) 1 wherein R 1 , R 2 , R 3 , R 4 , R 5 and n are as defined in the description and claims and pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof. The compounds are useful for the treatment of diseases which are associated with cysteine proteases such as osteoporosis, osteoarthritis, rheumatoid arthritis, tumor metastasis, glomerulonephritis, atherosclerosis, myocardial infarction, angina pectoris, instable angina pectoris, stroke, plaque rupture, transient ischemic attacks, amaurosis fugax, peripheral arterial occlusive disease, restenosis after angioplasty and stent placement, abdominal aortic aneurysm formation, inflammation, autoimmune disease, malaria, ocular fundus tissue cytopathy and respiratory disease.

  本发明涉及以下式（I）的化合物 1 其中R 1 ，R 2 ，R 3 ，R 4 ，R 5 和n如描述和索赔中所定义，并且其药学上可接受的盐和/或药学上可接受的酯。这些化合物可用于治疗与半胱氨酸蛋白酶相关的疾病，如骨质疏松症、骨关节炎、类风湿关节炎、肿瘤转移、肾小球肾炎、动脉粥样硬化、心肌梗死、心绞痛、不稳定性心绞痛、中风、斑块破裂、短暂性缺血发作、短暂性视网膜动脉阻塞、外周动脉闭塞症、血管成形术后再狭窄和支架植入术后再狭窄、腹主动脉瘤形成、炎症、自身免疫疾病、疟疾、眼底组织细胞病变和呼吸道疾病。
• Studies on anti-Fusarium disease activity of aminonitrile derivatives. I. Preventive activities of N-substituted-.ALPHA.-aminonitriles against Fusarium diseases.
  作者：Osamu KIRINO、Hirofumi OSHITA、Tadashi OISHI、Toshiro KATO

  DOI：10.1271/bbb1961.44.25

  日期：——

  Forty nine N-substituted-α-aminonitriles were prepared and their preventive activities against Fusarium diseases were determined. Relationships between chemical structure and preventive activity were examined and the systemic movement in plants was investigated with 14C-N-allylaminoacetonitrile. Of the compounds tested, N-sec-butyl-α-aminoisobutyronitrile and N-allylaminoacetonitrile were most effective in controlling yellows of the Japanese radish which were caused by Fusarium oxvsporum f. sp. raphani. N-Allylaminoacetonitrile showed remarkable systemic movement and a potent preventive activity against Fusarium wilts of cucumber and tomato not only by the soil drench test but also by the foliar spray assay.

  制备了49种代N-取代-α-氨基腈，并测定了它们对镰刀菌病害的防治活性。研究了化学结构与防治活性之间的关系，并使用14C-N-烯丙基氨基乙腈研究了其在植物中的系统运动。在测试的化合物中，N-仲丁基-α-氨基异丁腈和N-烯丙基氨基乙腈对由尖孢镰刀菌萝卜专化型引起的日本萝卜黄化病具有最佳的防治效果。N-烯丙基氨基乙腈显示出卓越的系统运动，对黄瓜和番茄的镰刀菌萎蔫病不仅通过土壤浸渍测试，还通过叶面喷雾法表现出强效的预防活性。